Additionally, detailed studies on the functional mechanisms of NEAT1, MEG3, and MALAT1 will be essential for elucidating their roles in diagnosing and treating NAFLD, NASH, and fibrosis. This evidence concerns the gene MALAT1 and metabolic dysfunction-associated steatotic liver disease.